deltatrials
Completed PHASE4 NCT00183729

Memantine Treatment for Improving Rehabilitation Outcomes and Preventing Depression in Older Adults

Memantine for Enhancement of Rehabilitation Efficacy and Prevention of Major Depressive Disorder in Older Adults

Sponsor: Eric Lenze

Conditions Depression
Interventions Memantine Placebo
Updated 9 times since 2017 Last updated: Dec 18, 2017 Started: Aug 31, 2005 Primary completion: Jun 30, 2009 Completion: Jun 30, 2009

This PHASE4 trial investigates Depression and is currently completed. Eric Lenze leads this study, which shows 9 recorded versions since 2005 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE4

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE4

  5. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE4

▶ Show 4 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  2. Feb 2018 — Jun 2018 [monthly]

    Completed PHASE4

  3. Feb 2017 — Feb 2018 [monthly]

    Completed PHASE4

  4. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE4

    First recorded

Aug 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Eric Lenze
  • National Institute of Mental Health (NIMH)
Data source: University of Pittsburgh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Pittsburgh, United States